A Research Of The Growth Of The Qianjin Pharmaceutical Based On Harvard Analysis Framework

Traditional Chinese medicine is a treasure of China’s traditional cultural heritage,with a development history of over 5000 years.It is the crystallization of the wisdom of the Chinese civilization for 5000 years and plays a very important role in the daily medical and health care of the people.The 14 th Five Year Plan "has elevated the development of traditional Chinese medicine in the new era to a national strategy and is an important component of building a moderately prosperous society in all respects.With the trend of aging population and the rise of health care in the field of sub health,the traditional Chinese medicine industry has ushered in new opportunities and also faced new challenges under the development of the times.The development of the listing of traditional Chinese medicine in the pharmaceutical industry is a key part of the development of the traditional Chinese medicine industry.At the same time,the growth of enterprises can measure whether the listing of traditional Chinese medicine in the pharmaceutical industry is in line with the trend of industry development,whether it has the ability to win in fierce market competition,and whether it can be favored by investors and the capital market.This article selects Qianjin Pharmaceutical,a listed Chinese medicine company,as the research object,and conducts a study on its growth based on the Harvard analysis framework.After consulting a lot of documents,sorting out and studying the relevant theories,this paper mainly analyzes and studies the growth of enterprises from both vertical and horizontal aspects through the analysis framework of Kazakhstan and France and the factor analysis method.Compared with the traditional financial analysis,the Harvard analysis framework not only focuses on accounting analysis and financial analysis,but also focuses on the industry analysis and strategic analysis of the enterprise,especially the analysis and prediction of the enterprise development trend.Make the analysis of enterprises more comprehensive and specific.In the factor analysis method,20 listed Chinese medicine enterprises were selected for horizontal comparison,and the growth analysis model was established to make the growth analysis and research comparable.After consulting numerous literature,organizing and researching relevant theories,this article attempts to analyze and study the vertical and horizontal comparison of enterprises through a combination of Harvard analytical framework and factor analysis method,and obtain an evaluation of enterprise growth.Compared with traditional financial analysis,the Harvard analysis framework not only focuses on accounting analysis and financial analysis,but also focuses on industry analysis and strategic analysis of the enterprise,especially the analysis and prediction of the development trend of the enterprise,making the growth analysis of the enterprise more comprehensive and specific.In the factor analysis method,20 listed traditional Chinese medicine enterprises were selected for horizontal comparison,and a growth analysis model was established to make the growth analysis comparable and intuitive.The article first organizes research theories on corporate growth.The definition of enterprise growth,influencing factors,and the ability of an enterprise to fully integrate and utilize internal and external resources to continuously increase its value.Secondly,the basic situation of Qianjin Pharmaceutical was introduced,and the growth of Qianjin Pharmaceutical was analyzed and evaluated from four aspects:strategy,accounting,finance,and prospects.Strategic analysis shows that the enterprise has broad market prospects and good growth potential.Financial analysis shows that the company has insufficient growth through analysis of accounts receivable,inventory management,and fixed assets.Financial analysis compares it with 20 companies in the same industry and uses factor analysis method,which also indicates that the company has insufficient growth.Based on the previous three analyses,the prospect analysis concludes that the company lacks growth potential.Analyze again the reasons for the insufficient growth of enterprises,mainly due to insufficient endogenous growth motivation.Finally,suggestions for improving the growth potential of Qianjin Pharmaceutical are proposed,such as expanding sales,controlling costs,and enhancing scientific research capabilities.I hope that the analysis in this article can provide some help to the growth of Qianjin Pharmaceutical,provide reference for enterprises in the same industry,and provide some assistance to investors interested in investing in traditional Chinese medicine enterprises.